LOW BASED TRIPLE THERAPY FOR ELDERLY PATIENT WITH PRE-LIVER CIRRHOSIS HEPATITIS TYPE C CONTRIBUTES TO IMPROVE HEPATIC FUNCTIONAL RESERVE
TORU ISHIKAWA *
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
MICHITAKA IMAI
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
MASAYOSHI KO
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
HIROKI SATO
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
YUJIRO NOZAWA
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
TOMOE SANO
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
AKITO IWANAGA
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
KEIICHI SEKI
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
TERASU HONMA
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
TOSHIAKI YOSHIDA
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata, Japan
*Author to whom correspondence should be addressed.
Abstract
We present the case of an 80-year-old Japanese female suffering from a genotype 1b HCV infection, with a previous history of post-treatment relapse of PEG-IFN (interferon)/ribavirin (RBV). The patient was retreated with telaprevir-based triple therapy, she achieved rapid virological response (RVR). Despite dose reduction of treatment because of adverse effect (AE), she obtained a sustained virological response (SVR). Furthermore, hepatic functional reserve improved.
This case suggests that in selected genotype 1 HCV-infected patients, a successful treatment can be obtained even with a very low dose of these therapy because of AE or reduced compliance for elderly patient with fibrosis.
Keywords: Chronic hepatitis, telaprevir, elderly patients, hepatic functional reserve